Literature DB >> 20592245

Ca2+ overload and mitochondrial permeability transition pore activation in living delta-sarcoglycan-deficient cardiomyocytes.

Bodvaël Fraysse1, Sadia M Nagi, Belinda Boher, Hélène Ragot, Jeanne Lainé, André Salmon, Marc Y Fiszman, Marcel Toussaint, Yves Fromes.   

Abstract

Muscular dystrophies are often associated with significant cardiac disease that can be the prominent feature associated with gene mutations in sarcoglycan. Cardiac cell death is a main feature of cardiomyopathy in sarcoglycan deficiency and may arise as a cardiomyocyte intrinsic process that remains unclear. Deficiency of delta-sarcoglycan (delta-SG) induces disruption of the dystrophin-associated glycoprotein complex, a known cause of membrane instability that may explain cardiomyocytes cytosolic Ca2+ increase. In this study we assessed the hypothesis that cytosolic Ca2+ increase triggers cardiomyocyte death through mitochondrial Ca2+ overload and dysfunction in the delta-SG-deficient CHF147 hamster. We showed that virtually all isolated CHF147 ventricular myocytes exhibited elevated cytosolic and mitochondrial Ca2+ levels by the use of the Fura-2 and Rhod-2 fluorescent probes. Observation of living cells with Mito-Tracker red lead to the conclusion that approximately 15% of isolated CHF147 cardiomyocytes had disorganized mitochondria. Transmission electron microscope imaging showed mitochondrial swelling associated with crest and membrane disruption. Analysis of the mitochondrial permeability transition pore (MPTP) activity using calcein revealed that mitochondria of CHF147 ventricular cells were twofold leakier than wild types, whereas reactive oxygen species production was unchanged. Bax, Bcl-2, and LC3 expression analysis by Western blot indicated that the intrinsic apoptosis and the cell death associated to autophagy pathways were not significantly activated in CHF147 hearts. Our results lead to conclusion that cardiomyocytes death in delta-SG-deficient animals is an intrinsic phenomenon, likely related to Ca2+-induced necrosis. In this process Ca2+ overload-induced MPTP activation and mitochondrial disorganization may have an important role.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592245     DOI: 10.1152/ajpcell.00545.2009

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  18 in total

1.  A delta-sarcoglycan gene polymorphism as a risk factor for hypertrophic cardiomyopathy.

Authors:  Rosa M Ordoñez-Razo; Martín H Garrido-Garduño; Ramón A Pérez-Martínez; Victor M Ruiz; Esteban Herrera-Tepatlán; Maricela Rodríguez-Cruz; Ana L Jiménez-Vaca; Fernando Minauro-Sanmiguel; Fabio A Salamanca-Gómez
Journal:  Genet Test Mol Biomarkers       Date:  2012-04-23

2.  Genetic ablation of ryanodine receptor 2 phosphorylation at Ser-2808 aggravates Ca(2+)-dependent cardiomyopathy by exacerbating diastolic Ca2+ release.

Authors:  Bin Liu; Hsiang-Ting Ho; Florencia Velez-Cortes; Qing Lou; Carmen R Valdivia; Bjorn C Knollmann; Hector H Valdivia; Sandor Gyorke
Journal:  J Physiol       Date:  2014-01-20       Impact factor: 5.182

3.  Enhanced Ca²⁺ influx from STIM1-Orai1 induces muscle pathology in mouse models of muscular dystrophy.

Authors:  Sanjeewa A Goonasekera; Jennifer Davis; Jennifer Q Kwong; Federica Accornero; Lan Wei-LaPierre; Michelle A Sargent; Robert T Dirksen; Jeffery D Molkentin
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

4.  Peroxisome proliferator-activated receptor γ coactivator1- gene α transfer restores mitochondrial biomass and improves mitochondrial calcium handling in post-necrotic mdx mouse skeletal muscle.

Authors:  Richard Godin; Frederic Daussin; Stefan Matecki; Tong Li; Basil J Petrof; Yan Burelle
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

5.  (-)-Epicatechin improves mitochondrial-related protein levels and ameliorates oxidative stress in dystrophic δ-sarcoglycan null mouse striated muscle.

Authors:  Israel Ramirez-Sanchez; Sergio De los Santos; Silvia Gonzalez-Basurto; Patricia Canto; Patricia Mendoza-Lorenzo; Carlos Palma-Flores; Guillermo Ceballos-Reyes; Francisco Villarreal; Alejandro Zentella-Dehesa; Ramon Coral-Vazquez
Journal:  FEBS J       Date:  2014-10-30       Impact factor: 5.542

6.  Mitochondrial alterations and oxidative stress in an acute transient mouse model of muscle degeneration: implications for muscular dystrophy and related muscle pathologies.

Authors:  Renjini Ramadasan-Nair; Narayanappa Gayathri; Sudha Mishra; Balaraju Sunitha; Rajeswara Babu Mythri; Atchayaram Nalini; Yashwanth Subbannayya; Hindalahalli Chandregowda Harsha; Ullas Kolthur-Seetharam; Muchukunte Mukunda Srinivas Bharath
Journal:  J Biol Chem       Date:  2013-11-12       Impact factor: 5.157

7.  SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals.

Authors:  Sophie Bouyon; Véronique Roussel; Yves Fromes
Journal:  Hum Gene Ther       Date:  2014-08       Impact factor: 5.695

8.  Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy.

Authors:  Alison Blain; Elizabeth Greally; Steve Laval; Andrew Blamire; Volker Straub; Guy A MacGowan
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

9.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

10.  Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathy.

Authors:  Elizabeth Greally; Benjamin J Davison; Alison Blain; Steve Laval; Andrew Blamire; Volker Straub; Guy A MacGowan
Journal:  J Cardiovasc Magn Reson       Date:  2013-01-16       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.